Tauns Laboratories (TYO:197A) has withdrawn its application to shift to the Tokyo Stock Exchange's Prime Market, citing delays in the review process and the need to revise submitted materials, according to a Monday filing on the Tokyo Stock Exchange.
The company had submitted the application using the fiscal year ended June 2024 as its reference period, but now expects the Tokyo bourse will not approve it before its upcoming shareholder meeting in September.
Tauns said it still aims to pursue a move to the Prime Market and will reassess the timing.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。